Messer has reported its strongest financial performance to date in 2024, driven by regional expansion and sustained investment across core markets.
The privately owned industrial, medical and specialty gases company posted group sales of approximately €4.5bn ($4.8bn), up 2% year-on-year. Earnings before tax and depreciation rose 10% to €1.4bn ($1.5bn), supported by new plant start-ups, a broader mix of customers, and strong demand from aerospace, semiconductors and healthcare.
CEO Bernd Eulitz said the company’s diverse footprint and local production model helped its resilience.
“The industrial gases business proves resilient even in globally challenging times…. The vast majority of our products are produced locally to serve local customers, with only limited cross-border business.”
… to continue reading this article and more, please login, register for free, or consider subscribing to gasworld
